Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)
Sanofi's Growth Prospects Bolstered by Promising Drug Pipeline and Strategic Corporate Actions: A Buy Rating Review
Sanofi (SNYNF) Receives a Hold From J.P. Morgan
Sanofi (SNYNF) Receives a Hold From Kepler Capital
Sanofi Analyst Ratings
Argus Research Maintains Sanofi(SNY.US) With Buy Rating, Raises Target Price to $60
DZ BANK AG Remains a Hold on Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Universal Health (UHS) and Sanofi (OtherSNYNF)
Sanofi: Strong Q2 Performance and Promising Outlook Justify Buy Rating
Sanofi 2Q Business Operating Income EUR2.81B
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Sanofi (SNYNF) Gets a Sell From Deutsche Numis
UBS Sticks to Their Buy Rating for Sanofi (SNYNF)
Jefferies Remains a Buy on Sanofi (SNYNF)
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
Wedbush Adjusts Price Target on Vigil Neuroscience to $23 From $22 on Heels of Sanofi Investment, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Cellectis SA (CLLS) and Sanofi (OtherSNYNF)